Condition
Crohn's Diseases
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Not Yet Recruiting2
Unknown2
Clinical Trials (4)
Showing 4 of 4 trials
NCT07424040Not ApplicableNot Yet RecruitingPrimary
The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children
NCT07415473Phase 4Not Yet RecruitingPrimary
Akkermansia Muciniphila Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease
NCT02675153Not ApplicableUnknownPrimary
To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture
NCT02897661Not ApplicableUnknownPrimary
Washed Microbiota Transplantation Improves Nutritional Status of Patients With Crohn's Disease
Showing all 4 trials